tegafur has been researched along with Klatskin Tumor in 2 studies
Klatskin Tumor: Cholangiocarcinoma arising near or at the confluence of the right and left hepatic ducts (COMMON HEPATIC DUCT). These tumors are generally small, sharply localized, and seldom metastasizing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although the combination of cisplatin and gemcitabine (GEM) is considered the standard first-line chemotherapy against unresectable hilar cholangiocarcinoma (HC), its efficacy is discouraging." | 9.22 | Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial. ( Guan, J; Li, H; Tong, DN; Zhang, ZY; Zhou, GW; Zhou, ZQ, 2016) |
| "Although the combination of cisplatin and gemcitabine (GEM) is considered the standard first-line chemotherapy against unresectable hilar cholangiocarcinoma (HC), its efficacy is discouraging." | 5.22 | Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial. ( Guan, J; Li, H; Tong, DN; Zhang, ZY; Zhou, GW; Zhou, ZQ, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosoda, K | 1 |
| Fukushima, K | 1 |
| Shimizu, A | 1 |
| Motoyama, H | 1 |
| Kubota, K | 1 |
| Notake, T | 1 |
| Sugenoya, S | 1 |
| Hayashi, H | 1 |
| Yasukawa, K | 1 |
| Kobayashi, R | 1 |
| Soejima, Y | 1 |
| Li, H | 1 |
| Zhang, ZY | 1 |
| Zhou, ZQ | 1 |
| Guan, J | 1 |
| Tong, DN | 1 |
| Zhou, GW | 1 |
1 trial available for tegafur and Klatskin Tumor
| Article | Year |
|---|---|
Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; CA-19-9 Antigen; D | 2016 |
1 other study available for tegafur and Klatskin Tumor
| Article | Year |
|---|---|
Survival Outcomes of Gemcitabine Plus S-1 Adjuvant Chemotherapy after Surgical Resection for Advanced Biliary Tract Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2021 |